Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Carl Zeiss Meditec
AddedFeb 17, 2024
UpdatedJun 28, 2026
Carl Zeiss Meditec

Carl Zeiss Meditec

Public

Global leader in ophthalmic medical technology solutions.

HQ
Jena, Thuringia, DE
Founded
2002
Overview
Compare
Employees

Carl Zeiss Meditec AG is a global leader in ophthalmic medical technology solutions. The company offers comprehensive system solutions, including screening, diagnostic, and therapeutic systems for treating vision defects, cataracts, glaucoma, and retinal disorders. With a strong market presence, Carl Zeiss Meditec operates worldwide, including subsidiaries in the USA and Japan.

The company has made significant advancements in medical technology, contributing to improved patient outcomes in ophthalmology. Its innovative products and global reach have established Carl Zeiss Meditec as a key player in the medical technology sector, enhancing the quality of eye care globally.

Carl Zeiss Meditec - Similar Companies

Zeiss logo

Zeiss

zeiss.com

STAAR Surgical logo

STAAR Surgical

staar.com

Bausch & Lomb logo

Bausch & Lomb

bausch.com

Ocular Therapeutix logo

Ocular Therapeutix

ocutx.com

Alcon logo

Alcon

alcon.com

Siemens Healthineers logo

Siemens Healthineers

Aier Eye Hospital Group logo

Aier Eye Hospital Group

aierchina.com

Medtronic logo

Medtronic

medtronic.com

Atia Vision logo

Atia Vision

atiavision.com

Laborie logo

Laborie

laborie.com

EyePoint logo

EyePoint

Ace Vision Group logo

Ace Vision Group

acevisiongroup.com

Concept Medical logo

Concept Medical

conceptmedical.com

Olympus logo

Olympus

olympus.com

Pentax Medical logo

Pentax Medical

Carl Zeiss Meditec - Quick Facts

Who are Carl Zeiss Meditec's competitors?

Companies similar to Carl Zeiss Meditec include Zeiss, STAAR Surgical, Bausch & Lomb and Ocular Therapeutix.

When was Carl Zeiss Meditec founded?

Carl Zeiss Meditec was founded in 2002.

Where is Carl Zeiss Meditec's headquarters located?

Carl Zeiss Meditec's headquarters is located in Jena, Thuringia, DE.

How many employees does Carl Zeiss Meditec have?

Carl Zeiss Meditec has 3,531 employees as of Feb 12, 2024.

Carl Zeiss Meditec - Classification

Industry
  • Hardware
Ownership
  • Public
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
  • Ophthalmology
Tags
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
ISIC
  • 2670Manufacture of optical instruments and photographic equipment
  • 3250Manufacture of medical and dental instruments and supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified